Urine pH, container composition, and exposure time influence adsorptive loss of 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid

被引:20
作者
Jamerson, MH [1 ]
McCue, JJ [1 ]
Klette, KL [1 ]
机构
[1] Navy Drug Screening Lab, Great Lakes, IL 60088 USA
关键词
D O I
10.1093/jat/29.7.627
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
11-nor-Δ9-Tetrahydrocannabinol-9-carboxylic acid (11-nor-Δ9-THC-COOH) is the primary cannabinoid present in the urine of individuals who have used marijuana and is the target analyte identified at forensic urinalysis drug testing laboratories. The preparation, storage, transport, and processing of control materials for gas chromatography-mass spectrometric (GC-MS) analysis of human urine specimens is critical to accurate compound identification and quantification. Previous studies have suggested that adsorptive loss of 11-nor-Δ9-THC- COOH is influenced by container composition and storage temperature. In this study, urine solutions of 11-nor-Δ9-THC-COOH (7.5, 15, 60, and 500 ng/mL) at three physiologically-relevant pHs (4.6, 6.5, and 8.4) were prepared and subjected to storage and processing in containers of different compositions (polypropylene and borosilicate glass). Analyte identification and quantification were achieved using tetramethylammonium hydroxide/iodomethane- based derivatization followed by GC separation and electron-impact MS. These analyses demonstrate that adsorptive loss of 11-nor-Δ9-THC-COOH is a phenomenon found in acidic urine solutions and is relatively absent in urine solutions that are near-neutral or basic. Furthermore, the data indicate that the adsorptive loss of 11-nor-Δ9-THC-COOH is dependent on solution-container exposure time and is similar between containers of two distinct compositions. These results suggest that for optimal analytical control performance, solution pH and control processing times are critical elements.
引用
收藏
页码:627 / 631
页数:5
相关论文
共 13 条
[1]  
BLANC JA, 1993, CLIN CHEM, V39, P1705
[2]   Prevalence of marijuana use disorders in the United States - 1991-1992 and 2001-2002 [J].
Compton, WM ;
Grant, BF ;
Colliver, JD ;
Glantz, MD ;
Stinson, FS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (17) :2114-2121
[3]  
*DHHS, 2003, 2002 NAT SURV DRUG U
[5]  
GOLDINGFRAGA S, 1998, ANN CLIN LAB SCI, V23, P160
[6]   Rapid quantification of urinary 11-nor-Δ9-tetrahydrocannabinol-9-carboxylic acid using fast gas chromatography-mass spectrometry [J].
Jamerson, MH ;
Welton, RM ;
Morris-Kokski, CL ;
Klette, KL .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2005, 29 (07) :664-668
[8]  
MOORE FML, 1991, MED LAB SCI, V48, P76
[9]  
PAUL BD, 1993, J ANAL TOXICOL, V17, P376
[10]  
ROMBERG RW, 1994, J FORENSIC SCI, V39, P479